Philadelphia partner Kathryn Doyle will moderate a panel discussing what every investigator, entrepreneur, investor and their patent attorney should know about intellectual property in biotechnology startup companies. In addition to discussing current hot issues in biotech and devices, the session will cover recent developments in US/PCT/TRIPS policies as related to biotech and devices, claims development strategy, managing the freedom to operate process, jurisdiction strategy and partnering implications.